trans-4-<(1E)-(3-phosphonoprop-2-enyl)>piperidine-2-carboxylic acid | 121570-58-9

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: trans-4-<(1E)-(3-phosphonoprop-2-enyl)>piperidine-2-carboxylic acid
• 英文别名: (2R,4R)-4-[(E)-3-phosphonoprop-2-enyl]piperidine-2-carboxylic acid
• CAS: 121570-58-9
• 化学式: C₉H₁₆NO₅P
• 分子量: 249.203
• InChiKey: KWMQTYXPEOXMJB-TXBDQOJXSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.3
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.67
• 拓扑面积：
  107
• 氢给体数：
  4
• 氢受体数：
  6

反应信息

• 作为反应物：
  描述：

  trans-4-<(1E)-(3-phosphonoprop-2-enyl)>piperidine-2-carboxylic acid 在 palladium on activated charcoal 氢气 作用下， 以 水 为溶剂， 反应 3.0h， 以100%的产率得到trans-4-(3-phosphonopropyl)piperidine-2-carboxylic acid
  参考文献：
  名称：

  4-(Phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors and anticonvulsant activity

  摘要：

  A series of 4-(phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids were synthesized, and their biological activity was assessed as competitive ligands for the NMDA receptor, both in vitro by using a receptor binding assay ([3H]CGS 19755 binding) and in vivo by using an NMDA seizure model in mice. The analogues were also evaluated in [3H]AMPA and [3H]kainate binding to assess their affinity for non-NMDA excitatory amino acid receptor subtypes. A number of these analogues show potent and selective NMDA antagonistic activity both in vitro and in vivo. Most notable are 4-(phosphonomethyl)-2-piperidinecarboxylic acid (1a) (CGS 19755) and the phosphonopropenyl analogue 1i, both of which show anticonvulsant activity in the 1-2 mg/kg ip range. With the aid of computer-assisted modeling, a putative bioactive conformation for AP-5 is hypothesized from the SAR data presented and a preliminary model for the antagonist-preferring state of the NMDA receptor is presented.

  DOI：

  10.1021/jm00129a025
• 作为产物：
  描述：

  4-(2-羟乙基)吡啶 在 platinum(IV) oxide 吡啶 、 咪唑 、 盐酸 、 正丁基锂 、 氢气 、 sodium 、 potassium carbonate 、 三乙胺 、 间氯过氧苯甲酸 、 pyridinium chlorochromate 作用下， 以 四氢呋喃 、 乙醇 、 正己烷 、 二氯甲烷 、 溶剂黄146 、 N,N-二甲基甲酰胺 为溶剂， 反应 4.5h， 生成 trans-4-<(1E)-(3-phosphonoprop-2-enyl)>piperidine-2-carboxylic acid
  参考文献：
  名称：

  4-(Phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors and anticonvulsant activity

  摘要：

  A series of 4-(phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids were synthesized, and their biological activity was assessed as competitive ligands for the NMDA receptor, both in vitro by using a receptor binding assay ([3H]CGS 19755 binding) and in vivo by using an NMDA seizure model in mice. The analogues were also evaluated in [3H]AMPA and [3H]kainate binding to assess their affinity for non-NMDA excitatory amino acid receptor subtypes. A number of these analogues show potent and selective NMDA antagonistic activity both in vitro and in vivo. Most notable are 4-(phosphonomethyl)-2-piperidinecarboxylic acid (1a) (CGS 19755) and the phosphonopropenyl analogue 1i, both of which show anticonvulsant activity in the 1-2 mg/kg ip range. With the aid of computer-assisted modeling, a putative bioactive conformation for AP-5 is hypothesized from the SAR data presented and a preliminary model for the antagonist-preferring state of the NMDA receptor is presented.

  DOI：

  10.1021/jm00129a025

文献信息

• HUTCHISON, ALAN J.;WILLIAMS, MICHAEL;ANGST, CHRISTOFF;JESUS, REYNALDA DE;+, J. MED. CHEM., 32,(1989) N, C. 2171-2178
  作者：HUTCHISON, ALAN J.、WILLIAMS, MICHAEL、ANGST, CHRISTOFF、JESUS, REYNALDA DE、+

  DOI：——

  日期：——
• 4-(Phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids: synthesis, activity at N-methyl-D-aspartic acid receptors and anticonvulsant activity
  作者：Alan J. Hutchison、Michael Williams、Christoff Angst、Reynalda De Jesus、Louis Blanchard、Robert H. Jackson、E. Jay Wilusz、Deborah E. Murphy、Patrick S. Bernard

  DOI：10.1021/jm00129a025

  日期：1989.9

  A series of 4-(phosphonoalkyl)- and 4-(phosphonoalkenyl)-2-piperidinecarboxylic acids were synthesized, and their biological activity was assessed as competitive ligands for the NMDA receptor, both in vitro by using a receptor binding assay ([3H]CGS 19755 binding) and in vivo by using an NMDA seizure model in mice. The analogues were also evaluated in [3H]AMPA and [3H]kainate binding to assess their affinity for non-NMDA excitatory amino acid receptor subtypes. A number of these analogues show potent and selective NMDA antagonistic activity both in vitro and in vivo. Most notable are 4-(phosphonomethyl)-2-piperidinecarboxylic acid (1a) (CGS 19755) and the phosphonopropenyl analogue 1i, both of which show anticonvulsant activity in the 1-2 mg/kg ip range. With the aid of computer-assisted modeling, a putative bioactive conformation for AP-5 is hypothesized from the SAR data presented and a preliminary model for the antagonist-preferring state of the NMDA receptor is presented.